INS and cancer: These pathways included the expression of PD-L1 in cancer and the PD-1 checkpoint pathway, AGE-RAGE signaling in diabetic complications, insulin secretion, insulin resistance, and the differentiation of T cells, B cells, and other cell types (Fig. 4A–F).